소개
Central Nervous System (CNS) tumors remain among the most challenging conditions in modern medicine, because clinical decisions are often made under time pressure and uncertainty. Diagnosis and treatment planning increasingly depend on data spanning radiology, radiotracer imaging, intraoperative assessment, histopathology, cytogenomics, epigenetic profiling, circulating biomarkers, and longitudinal response evaluation.